The German healthcare system is undergoing a period of profound change. The hospital reform has initiated a politically driven structural transformation aimed at ensuring high-quality, economically sustainable, long-term, accessible, and needs-based healthcare for the population. At the same time, current legislative measures, particularly those intended to stabilize statutory health insurance (GKV) contributions, are placing significant financial pressure on many hospitals.
As Dr. Gerald Gaß, Chairman of the German Hospital Federation (DKG), has pointed out, a planned structural transformation risks turning into an “uncontrolled loss of substance.”
Particularly in rural regions, there is a growing risk of gaps in healthcare provision if existing hospital structures disappear without adequate alternative care models being established.
To prevent this outcome, hospitals require above all planning certainty, reliability, and a strong political commitment to work together with the federal states to develop sustainable solutions for the future of healthcare delivery.
Modern healthcare must not be constrained by the traditional boundaries between inpatient and outpatient care. Instead, it should be consistently aligned with current healthcare needs. The outpatient capabilities of hospitals should therefore be further expanded and utilized more effectively as part of an integrated care approach.
At the same time, another important aspect of healthcare is often underestimated: hospitals are not only providers of care but also centers of medical innovation. Innovative medical technologies and treatment approaches are frequently perceived by decision-makers and self-governing healthcare bodies primarily as cost drivers. Yet innovative therapies can play a crucial role in addressing some of the most pressing challenges facing the German healthcare system. They have the potential to reduce capacity constraints, improve clinical outcomes, and increase the efficiency of healthcare delivery.
Recent developments, however, suggest that the value of innovation is not always adequately recognized. The new regulations governing New Examination and Treatment Methods (NUB) as well as e.g., the withdrawal of the DiGA status of sinCephalea despite positive clinical study results raise important questions about whether the current understanding of what is necessary for modern patient care is too narrowly defined.
At Healthcare Heads, we believe that these developments are unlikely to achieve the intended cost savings. On the contrary, limiting access to beneficial innovations may result in missed opportunities to improve patient outcomes, optimize resource utilization, and address structural challenges within the healthcare system.
A future-proof healthcare system therefore requires both economically sustainable care structures and reliable access to medical innovation. Only by considering these two perspectives together can the challenges facing the German healthcare system be addressed in a sustainable way.
What Is Your Opinion?
How can structural healthcare reforms and medical innovation work together more effectively to ensure high-quality patient care for the future?
We would be delighted to hear your perspective and continue the discussion on LinkedIn.
Author: Healthcare Heads GmbH
Phone: +49 431 800 1470
E-Mail: info@healthcareheads.com